Ovulation induction.
Induction of ovulation is indicated for anovulatory and amenorrheic women as well as for women who have an inadequate luteal phase. It is also indicated as a strategy for recruiting multiple follicles for women with unexplained infertility and those who are undergoing assisted reproductive technologies. The use of various agents and detection of ovulation are described. This includes a discussion of clomiphene citrate, bromocriptine, human menopausal gonadotropins, urinary follicle stimulating hormone and pulsatile gonadotropin releasing hormone therapy. Regimens, success rates and potential complications of each form of therapy are reviewed. Also discussed is the use of combination therapy and partial ovarian destruction.
March
C M
CM
University of Southern California School of Medicine, Department of Obstetrics and Gynecology, Los Angeles.
D001971:Bromocriptine; D002996:Clomiphene; D005260:Female; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D008596:Menotropins; D010062:Ovulation Induction / Q000379:methods*
D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D001971:Bromocriptine; D008596:Menotropins